Source disclosure: February 13, 2026
TAIKO PHARMACEUTICAL CO.,LTD. [4574.T]
TOKYO, Feb 19 (Pulse News Wire) – Taiko Pharmaceutical Co., Ltd. (4574.T) reported consolidated results for fiscal year 2025 ending December.
40 billion (+1.7% YoY). 1%). net profit attributable to shareholders was ¥923 million (+2.8%).
3 billion with an equity ratio of 69.4%. For the next fiscal year, the company forecasts 20 billion (+12.5%).
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2025/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥6,397M | +1.7% |
| Operating profit | ¥459M | -27.1% |
| Net profit | ¥923M | +2.8% |
Next period forecast
Revenue
¥7,200M
+12.5%Op. profit
¥500M
+8.9%Net profit
¥550M
-40.4%Source: TDNet filing · Figures in millions of yen